Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia Considers Delay In H1N1 Vaccine Distribution To Next Winter

This article was originally published in PharmAsia News

Executive Summary

The Australian government has decided to be cautious in releasing the millions of doses of H1N1 flu vaccine it has ordered from drug maker CSL. The vaccine is currently in clinical trials and reportedly proceeding smoothly through the process. CSL says its vaccine could be ready for distribution by the end of August, but the government could delay distributing from its stockpile until the nation's next winter season. The government already has ruled out early distribution to the elderly, patients with chronic illnesses and others considered vulnerable. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts